A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Phase 2 Completed
74 enrolled
LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Phase 3 Completed
545 enrolled 24 charts
Néofirinox
Phase 3 Completed
461 enrolled
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
Phase 1/2 Completed
48 enrolled 24 charts
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Phase 1/2 Completed
169 enrolled
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Phase 1 Completed
279 enrolled
IVY
Phase 1 Completed
353 enrolled
A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors
Phase 1 Completed
23 enrolled
TASCO1
Phase 2 Completed
154 enrolled 15 charts
A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer
Phase 1 Completed
165 enrolled
Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")
Phase 2 Completed
229 enrolled 14 charts
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Phase 1 Completed
65 enrolled
ALTER-C-002
Phase 2 Completed
30 enrolled
Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
Phase 3 Completed
499 enrolled 22 charts
TreeTopp
Phase 2/3 Completed
151 enrolled 18 charts
Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Phase 3 Completed
1,221 enrolled 18 charts
Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer
Phase 1 Completed
14 enrolled
Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight
Phase NA Completed
8 enrolled 7 charts
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Phase 1 Completed
30 enrolled
Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.
Phase 1 Completed
88 enrolled
Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines
Phase NA Completed
1,103 enrolled
Phase II Study for Solid Metastatic Tumors
Phase 2 Completed
41 enrolled
VITAL
Phase 2 Completed
112 enrolled 15 charts
Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies
Phase 1 Completed
25 enrolled
Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer
Phase 2 Completed
40 enrolled 8 charts
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase 1 Completed
51 enrolled
Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer
Phase 1/2 Completed
34 enrolled
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
Phase 2 Completed
68 enrolled 16 charts
LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients
Phase 1 Completed
20 enrolled 5 charts
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.
Phase 2 Completed
83 enrolled 18 charts
Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma
Phase 1 Completed
13 enrolled
Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer
Phase 2 Completed
63 enrolled 9 charts
Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines
Phase 1 Completed
22 enrolled
Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer
Phase 2 Completed
52 enrolled
Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors
Phase 1 Completed
30 enrolled
Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors
Phase 1 Completed
32 enrolled
Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer
Phase 2 Completed
41 enrolled 13 charts
COBRA
Phase 1 Completed
32 enrolled
Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma
Phase 1 Completed
15 enrolled
Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor
Phase 1 Completed
102 enrolled 48 charts
Preoperative Chemoradiation With Capecitabine and Cetuximab
Phase 2 Completed
31 enrolled
Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine
Phase 1 Completed
Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer
Phase 2 Completed
46 enrolled
Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan
Phase 1 Completed
21 enrolled
Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC
Phase 2/3 Completed
224 enrolled